Christian MC - Search Results

1

4-Ipomeanol: a novel investigational new drug for lung cancer.

Christian MC, Wittes RE, Leyland-Jones B, McLemore TL, Smith AC, Grieshaber CK, Chabner BA, Boyd MR. Christian MC, et al. J Natl Cancer Inst. 1989 Aug 2;81(15):1133-43. doi: 10.1093/jnci/81.15.1133. J Natl Cancer Inst. 1989. PMID: 2664191 Review.

2

Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans.

Rowinsky EK, Noe DA, Ettinger DS, Christian MC, Lubejko BG, Fishman EK, Sartorius SE, Boyd MR, Donehower RC. Rowinsky EK, et al. Among authors: christian mc. Cancer Res. 1993 Apr 15;53(8):1794-801. Cancer Res. 1993. PMID: 8467498 Clinical Trial.

3

Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trials.

Fisherman JS, Osborn BL, Chun HG, Plowman J, Smith AC, Christian MC, Zaharko DS, Shoemaker RH. Fisherman JS, et al. Among authors: christian mc. Invest New Drugs. 1993 Feb;11(1):1-9. doi: 10.1007/BF00873904. Invest New Drugs. 1993. PMID: 8349430 Review.

4

Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer.

Kasturi VK, Dearing MP, Piscitelli SC, Russell EK, Sladek GG, O'Neil K, Turner GA, Morton TL, Christian MC, Johnson BE, Kelley MJ. Kasturi VK, et al. Among authors: christian mc. Clin Cancer Res. 1998 Sep;4(9):2095-102. Clin Cancer Res. 1998. PMID: 9748125 Clinical Trial.

5

A central institutional review board for multi-institutional trials.

Christian MC, Goldberg JL, Killen J, Abrams JS, McCabe MS, Mauer JK, Wittes RE. Christian MC, et al. N Engl J Med. 2002 May 2;346(18):1405-8. doi: 10.1056/NEJM200205023461814. N Engl J Med. 2002. PMID: 11986418 No abstract available.

6

Clinical development of Taxol.

Arbuck SG, Christian MC, Fisherman JS, Cazenave LA, Sarosy G, Suffness M, Adams J, Canetta R, Cole KE, Friedman MA. Arbuck SG, et al. Among authors: christian mc. J Natl Cancer Inst Monogr. 1993;(15):11-24. J Natl Cancer Inst Monogr. 1993. PMID: 7912517 Review.

7

Accelerated titration designs for phase I clinical trials in oncology.

Simon R, Freidlin B, Rubinstein L, Arbuck SG, Collins J, Christian MC. Simon R, et al. Among authors: christian mc. J Natl Cancer Inst. 1997 Aug 6;89(15):1138-47. doi: 10.1093/jnci/89.15.1138. J Natl Cancer Inst. 1997. PMID: 9262252

8

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.

Kohn EC, Sarosy G, Bicher A, Link C, Christian M, Steinberg SM, Rothenberg M, Adamo DO, Davis P, Ognibene FP, et al. Kohn EC, et al. J Natl Cancer Inst. 1994 Jan 5;86(1):18-24. doi: 10.1093/jnci/86.1.18. J Natl Cancer Inst. 1994. PMID: 7505830 Clinical Trial.

9

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.

Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, Sausville EA. Johnson JI, et al. Br J Cancer. 2001 May 18;84(10):1424-31. doi: 10.1054/bjoc.2001.1796. Br J Cancer. 2001. PMID: 11355958 Free PMC article.

10

A reassessment of cardiac toxicity associated with Taxol.

Arbuck SG, Strauss H, Rowinsky E, Christian M, Suffness M, Adams J, Oakes M, McGuire W, Reed E, Gibbs H, et al. Arbuck SG, et al. J Natl Cancer Inst Monogr. 1993;(15):117-30. J Natl Cancer Inst Monogr. 1993. PMID: 7912518 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page